Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02807558
Title A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Syros Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.